Hemochromatosis (patient information)

Revision as of 17:52, 15 June 2010 by Ethanleeman (talk | contribs) (New page: '''For the WikiDoc page for this topic, click here''' {{SI}} '''Editor-in-Chief:''' Ethan Leeman {{EJ}} ==What is hemochromatosis?== Hemochromatosis occurs when the ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

For the WikiDoc page for this topic, click here

WikiDoc Resources for Hemochromatosis (patient information)

Articles

Most recent articles on Hemochromatosis (patient information)

Most cited articles on Hemochromatosis (patient information)

Review articles on Hemochromatosis (patient information)

Articles on Hemochromatosis (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemochromatosis (patient information)

Images of Hemochromatosis (patient information)

Photos of Hemochromatosis (patient information)

Podcasts & MP3s on Hemochromatosis (patient information)

Videos on Hemochromatosis (patient information)

Evidence Based Medicine

Cochrane Collaboration on Hemochromatosis (patient information)

Bandolier on Hemochromatosis (patient information)

TRIP on Hemochromatosis (patient information)

Clinical Trials

Ongoing Trials on Hemochromatosis (patient information) at Clinical Trials.gov

Trial results on Hemochromatosis (patient information)

Clinical Trials on Hemochromatosis (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemochromatosis (patient information)

NICE Guidance on Hemochromatosis (patient information)

NHS PRODIGY Guidance

FDA on Hemochromatosis (patient information)

CDC on Hemochromatosis (patient information)

Books

Books on Hemochromatosis (patient information)

News

Hemochromatosis (patient information) in the news

Be alerted to news on Hemochromatosis (patient information)

News trends on Hemochromatosis (patient information)

Commentary

Blogs on Hemochromatosis (patient information)

Definitions

Definitions of Hemochromatosis (patient information)

Patient Resources / Community

Patient resources on Hemochromatosis (patient information)

Discussion groups on Hemochromatosis (patient information)

Patient Handouts on Hemochromatosis (patient information)

Directions to Hospitals Treating Hemochromatosis (patient information)

Risk calculators and risk factors for Hemochromatosis (patient information)

Healthcare Provider Resources

Symptoms of Hemochromatosis (patient information)

Causes & Risk Factors for Hemochromatosis (patient information)

Diagnostic studies for Hemochromatosis (patient information)

Treatment of Hemochromatosis (patient information)

Continuing Medical Education (CME)

CME Programs on Hemochromatosis (patient information)

International

Hemochromatosis (patient information) en Espanol

Hemochromatosis (patient information) en Francais

Business

Hemochromatosis (patient information) in the Marketplace

Patents on Hemochromatosis (patient information)

Experimental / Informatics

List of terms related to Hemochromatosis (patient information)

Editor-in-Chief: Ethan Leeman

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

What is hemochromatosis?

Hemochromatosis occurs when the body absorbs too much iron from foods (and other sources such as vitamins containing iron). This disease causes extra iron to gradually build up in the body’s tissues and organs, a term called iron overload. Your body has no natural way to get rid of the extra iron. It stores it in body tissues, especially the liver, heart and pancreas. If this iron buildup is untreated, it can, over many years, damage the body’s organs.

What are the symptoms of hemochromatosis?

Hemochromatosis can have a variety of symptoms and symptoms may be different for men and women. Hemochromatosis can be hard to identify because early symptoms are similar to those of many other common diseases.

Although most people reach middle-age before they have symptoms of hemochromatosis, some people may have symptoms at a younger age. The symptoms depend on which organs are being affected by the iron buildup.

Early indications of hemochromatosis are often like those of other diseases and include the following symptoms:

  • Fatigue (feeling very tired)
  • Weakness
  • Weight loss
  • Abdominal pain
  • Joint pain

As iron builds up in the body organs, hemochromatosis may also produce the following symptoms:

  • Loss of menstrual periods or early menopause
  • Loss of sex drive (libido) or impotence
  • Loss of body hair
  • Shortness of breath

Although not a physical symptom, another possible indication of hemochromatosis is having an elevated liver enzyme test.

As the disease progresses, hemochromatosis may cause the following more serious problems:

  • Arthritis
  • Liver problems, such as cirrhosis (or scarring of the liver) and liver cancer
  • High blood sugar and diabetes
  • Abdominal pain that does not go away
  • Severe fatigue (feeling extremely tired and having a lack of energy)
  • Heart problems (such as a heart beat that is not regular)
  • Heart failure (such as the heart not pumping blood as well as it did previously)
  • Gray-colored or bronze-colored skin

Causes

The amount of iron the human body absorbs is controlled by many genes. Genes can sometimes change (or mutate) in ways that keep them from working properly.

Hereditary hemochromatosis can occur when a person inherits two mutated copies of a gene called the HFE gene — one from each parent. Men and women have the same chance of inheriting two copies of this gene.

Not everyone who is born with two copies of the mutated HFE gene develops the disease. Scientists do not know what percentage of people who have two copies of the mutated HFE gene develop the disease. Some studies have shown that as few as 1 in 100 people will develop symptoms. Other studies have shown that as many as 50 in 100 people may develop symptoms. A person with only one copy of the mutated HFE gene is usually healthy and is said to be a “carrier” of the genetic condition. Although a carrier usually does not have hemochromatosis, if both a mother and father are carriers, a child may inherit two copies of the mutated gene, one from each parent.

Who is at risk for hemochromatosis?

People who inherit the HFE gene mutation from both parents are at the greatest risk for developing hemochromatosis. Although both men and women can inherit the gene defect, men are more likely to be diagnosed with the effects of hemochromatosis than women. Other factors that increase risk are:

  • Ethnic Background: White people of northern European descent (for example, families from England, Ireland, Scotland, Denmark, France, and Scandinavia) have a higher chance of having the HFE gene mutation.
  • Family History: People with a close relative (grandparent, mother, father, sibling, niece, nephew) who has hemochromatosis have a higher chance of having the HFE gene mutation.

Diagnosis

When to seek urgent medical care

Treatment options

Diseases with similar symptoms

Where to find medical care for hemochromatosis

Directions to Hospitals Treating hemochromatosis

Prevention of hemochromatosis

What to expect (Outlook/Prognosis)

Sources

References

Template:SIB Template:WH Template:WS